D-0064-2021 Class III Terminated
FDA drug recall D-0064-2021 was initiated by Teligent Pharma, Inc. on Sep 28, 2020 and is designated Class III. Reason for recall: Failed Impurities/Degradation - Out-of-specification results for Fluocinolone Acetonide impurity. The recall status is terminated (terminated Aug 22, 2022). Affected quantity: 36,790 tubes.
Recall details
- Product Type
- Drugs
- Report Date
- Nov 11, 2020
- Initiation Date
- Sep 28, 2020
- Termination Date
- Aug 22, 2022
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 36,790 tubes
Product description
Fluocinonide Ointment USP 0.05%, packaged in: a) 15 gm tube, NDC 52565-0040-15, b) 30 gm tube, NDC 52565-0040-30 c) 60 gram tube, NDC 52565-0040-60, Rx only, Manufactured by: Teligent Pharma, Inc., Buena, New Jersey 08310
Reason for recall
Failed Impurities/Degradation - Out-of-specification results for Fluocinolone Acetonide impurity.
Distribution pattern
United States Nationwide
Code information
Lot#: a) 12250, Exp 10/2020; 15039, Exp 1/2022; 15573, Exp 7/2022; b) 12250, Exp 10/2020; 14589, 14848, Exp 12/2021; 15039, Exp 1/2022; 15245, Exp 2/2022; c) 12241, 12249, Exp 10/2020; 14222, Exp 8/2021; 15039, Exp 1/2022; 15037, 15246, Exp 2/2022; 15340, Exp 3/2022; 15387, Exp 4/2022
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0064-2021
- openFDA file date
- Nov 10, 2026
- Loaded by RegDataLab
- Nov 11, 2026